Buy Dihexa: High-Purity Research Grade Hexapeptide

Direct Sourcing Overview: High-Purity Dihexa for Laboratory Research

To buy Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) for laboratory experimentation, qualified researchers require a supplier that guarantees absolute chemical identity, stringent purity, and lot-to-lot consistency. PX1 Research provides USA-manufactured, third-party tested Dihexa synthesized specifically for non-clinical research applications, featuring verified purity exceeding 98% by RP-HPLC, complete mass spectrometry reporting, and lot-specific endotoxin testing.

When purchasing synthetic compounds for in vitro or animal models, raw purity dictates the validity of downstream observational data. Substandard reagents containing residual peptide fragments, heavy metals, or bacterial endotoxins can confound receptor-binding assays and cellular viability studies. Researchers evaluating options to buy Dihexa benefit from our transparent documentation framework, which attaches an independent Certificate of Analysis (COA) directly to every batch released from our ISO 17025 accredited testing facilities.

Biochemical Identity and Chemical Properties of Dihexa

Dihexa, also known by its developmental code PNB-0408, is an oligopeptide derivative designed as a stable, lipophilic analogue derived from the mammalian peptide angiotensin IV. Unlike native angiotensin IV, which exhibits a brief biological half-life due to rapid enzymatic degradation by circulating endopeptidases, Dihexa incorporates an N-terminal hexanoyl group and modified peptide linkages that substantially enhance structural stability in enzymatic assays.

The molecular formula of Dihexa is C27H44N4O5, possessing a molecular mass of approximately 504.66 g/mol. In solid form, the compound presents as a white to off-white lyophilized powder. Its structural modifications impart significant lipophilicity relative to unmodified hydrophilic peptides, making it a valuable candidate for studies exploring membrane permeability, blood-brain barrier penetration models, and intracellular receptor interaction.

Preclinical Synaptogenic Mechanism and HGF/c-Met Receptor Signaling

In preclinical literature, Dihexa is primary categorized as a high-affinity ligand for hepatocyte growth factor (HGF) and its tyrosine kinase receptor, c-Met (also known as MET). In vitro assay models indicate that Dihexa binds directly to HGF with picomolar affinity (Kd ≈ 65 pM), facilitating the dimerization of HGF and subsequent autophosphorylation of the c-Met receptor domain.

Activation of the c-Met signaling cascade triggers downstream intracellular pathways, including the Ras/Ref/MEK/ERK and PI3K/Akt pathways. Preclinical studies suggest that this signaling cascade plays a crucial role in promoting dendritic arborization, spinogenesis, and synaptogenesis in cultured hippocampal neurons. In animal models investigating cognitive dysfunction and neurodegeneration, administration of HGF-modulating compounds like Dihexa has been observed to stimulate the formation of new functional synaptic connections at concentrations significantly lower than conventional neurotrophic factors such as brain-derived neurotrophic factor (BDNF).

Researchers investigating synaptogenesis mechanisms utilize Dihexa to dissect the molecular architecture of activity-dependent synaptic plasticity, dendritic spine density, and neurostructural restoration without relying on recombinant viral vectors or unstable protein infusions.

Comparative Analysis: Dihexa and Related Research Peptides

When designing protocols to investigate neuroprotective or synaptogenic pathways, researchers often evaluate Dihexa alongside other specialized peptides in the same functional class. Understanding the biochemical distinctions between these compounds allows laboratories to select the optimal reagent for their specific experimental endpoints.

While Dihexa acts primarily via the HGF/c-Met axis to drive rapid dendritic spine formation, compounds such as Semax operate largely through the modulation of neurotrophin expression—specifically BDNF and nerve growth factor (NGF)—alongside melanocortin receptor interaction. Similarly, Selank demonstrates an immunomodulatory and GABAergic regulatory mechanism, influencing enkephalin stability rather than direct receptor tyrosine kinase autophosphorylation. Another notable compound in this space, N-Acetyl Semax Amidate, incorporates acetylated and amidated terminal modifications to extend peptide half-life in enzymatic assays, serving as an alternative tool for evaluating central nervous system signaling pathways. Comparing these agents in parallel assays allows investigators to isolate c-Met-dependent synaptogenesis from broader neurotrophin-mediated metabolic signaling.

Quality Verification: Third-Party COA, RP-HPLC, and Mass Spectrometry

In the research chemicals market, analytical transparency is non-negotiable. PX1 Research subjects every production lot of Dihexa to rigorous analytical testing at independent ISO 17025 certified laboratories based in the USA. We do not rely on manufacturer self-attestation or batch template reports.

Purity is quantified using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), which separates the target compound from synthesis byproducts, truncated sequences, and unreacted reagents. Our published COAs display the full UV absorbance chromatogram at 214 nm and 254 nm, confirming a purity profile of ≥98.0%. Identity is conclusively confirmed via Electrospray Ionization Mass Spectrometry (ESI-MS), verifying that the observed molecular weight matches the theoretical mass of Dihexa down to 0.1 Da.

Additionally, we conduct Chromogenic Reagent LAL Endotoxin Testing on every batch to ensure endotoxin levels remain below strictly defined threshold limits (<0.05 EU/mg). This renders our material suitable for sensitive cell culture, primary neuronal culture, and non-animal cellular assays where endotoxin contamination could induce unwanted inflammatory cascades or cell death. Researchers can inspect full testing documentation in our public analytical documentation hub.

Reconstitution, Solubility, and Storage Protocols for Laboratory Use

Proper handling and storage are critical to maintain the chemical integrity of lyophilized Dihexa during experimental trials. Due to its hydrophobic N-terminal hexanoyl modifications, Dihexa exhibits limited solubility in plain aqueous solutions such as standard phosphate-buffered saline (PBS) at neutral pH.

To achieve complete solubilization in laboratory settings, primary stock solutions are typically prepared using dimethyl sulfoxide (DMSO) or pure ethanol (EtOH). Once fully dissolved in organic solvent, stock solutions can be diluted into working culture media or physiological buffers, keeping the final organic solvent concentration below the toxicity threshold of the specific cellular assay (typically <0.1% v/v for neuronal cultures).

Lyophilized Dihexa should be stored upon receipt at -20°C in a desiccated container protected from light. Under these conditions, the unconstituted peptide remains stable for up to 24 months. Reconstituted stock solutions in DMSO should be aliquoted into small, single-use volumes and stored at -80°C to avoid repeated freeze-thaw cycles, which can induce physical aggregation or hydrolytic degradation over extended periods.

Preclinical Applications and In Vitro Experimental Models

In published academic literature, Dihexa serves as an invaluable molecular tool across several distinct experimental domains:

1. Primary Neuronal Outgrowth Assays: Used to quantify neurite elongation, branch point density, and postsynaptic density protein (PSD-95) clustering in embryonic rodent hippocampal and cortical cultures.

2. Models of Neurodegenerative Pathology: Investigated in cellular and animal models of Parkinsonian, Alzheimer's, and traumatic brain injury pathology to assess c-Met-mediated cell survival and functional recovery.

3. Synaptic Repair Mechanisms: Applied in electrophysiological slice preparations to evaluate Long-Term Potentiation (LTP) and miniature excitatory postsynaptic currents (mEPSCs) following chemical or mechanical injury.

4. Blood-Brain Barrier Transport Studies: Examined in artificial membrane permeability assays (PAMPA-BBB) and brain endothelial cell co-culture models to measure passive transcellular diffusion efficiency across tight junctions.

USA Manufacturing and Reliable Laboratory Logistics

Supply chain disruptions and inconsistent quality control from overseas synthesis vendors pose significant risks to ongoing academic and private research projects. PX1 Research mitigates these risks by maintaining pure USA manufacturing operations and domestic fulfillment hubs in California and Arizona.

Orders placed by qualified facilities are processed and shipped same-day (Monday through Friday), utilizing temperature-controlled, shock-resistant packaging to prevent thermal degradation during transit. Whether sourcing small quantities for preliminary feasibility studies or establishing a wholesale laboratory account for multi-phase clinical trial prep, institutional buyers can rely on rapid fulfillment and continuous supply stability.

Our catalog of neuroprotective research compounds and specialized signaling agents is continuously audited to guarantee compliance with strict chemical purity standards, enabling researchers to maintain continuous protocol execution without batch-to-batch variability.